...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New PP on SEDAR

Wish I had more Zenith and less RVX.

Then it boggles my mind why you wouldn't sell your RVX and buy ZHCLF.  With the tax loss, you'd get about a 1:1 swap of shares at current prices.  Are you suffering from metathesiophobia???

Share
New Message
Please login to post a reply